LESLIE STOVALL: Open Payments
NPI 1841615127 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 28 payments from 13 companies in 2025. Trend: 2023 $1,049 · 2024 $317 · 2025 $613
Food & beverage: $469Education: $144
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $191 |
| Lilly USA, LLC | 7 | $159 |
| MILLICENT US INC | 3 | $55 |
| Hologic Sales and Service, LLC | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $17 |
Products named: Veozah, ZEPBOUND, MOUNJARO, MYOSURE TISSUE REMOVAL DEVICE, FEMLYV, Mirena, Auvelity, ACCRUFER.
Industry payments across LA — which companies pay providers there.
